US 11566263
Compositions and methods for treating CEP290 associated disease
granted A61KA61K35/761A61K9/0048
Quick answer
US patent 11566263 (Compositions and methods for treating CEP290 associated disease) held by Editas Medicine, Inc. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K35/761, A61K9/0048